A New Benchmark for De-Aging Comes From Slowly Turning Back Cells’ Clocks
Researchers in Germany gradually reversed human cells’ ages by decades. By doing so, they could track the de-aging process in a way previous rejuvenation experiments could not.
Read More
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
Read More